A Long-term Follow-up Study in Subjects Who Received CTX001
A Long-term Follow-up Study in Subjects Who Received CTX001
This is a multi-site, observational study to evaluate the long-term safety and efficacy of
 CTX001 in subjects who received CTX001 in Study CTX001-111 (NCT03655678) or Study CTX001-121
 (NCT03745287).
Inclusion Criteria:

 -  Subjects or legal representative or guardian (if applicable) must sign and date
 informed consent form (ICF)

 -  Subjects must have received CTX001 infusion

 Exclusion Criteria:

 -  There are no exclusion criteria